| 0 |
LYMPHOID TISSUE HYPOPLASIA |
148 |
0.9673 |
| 1 |
THYMUS HYPOPLASIA |
151 |
0.8678 |
| 2 |
HUMAN BOCAVIRUS INFECTION |
133 |
0.7037 |
| 3 |
CYTARABINE SYNDROME |
39 |
0.5132 |
| 4 |
GEOTRICHUM INFECTION |
80 |
0.3791 |
| 5 |
STOMATOCOCCAL INFECTION |
41 |
0.3306 |
| 6 |
CYSTITIS BACTERIAL |
110 |
0.3254 |
| 7 |
NOROVIRUS TEST POSITIVE |
104 |
0.3200 |
| 8 |
MANTLE CELL LYMPHOMA RECURRENT |
126 |
0.2897 |
| 9 |
CAECITIS |
124 |
0.2756 |
| 10 |
HEPATOSPLENIC CANDIDIASIS |
39 |
0.2653 |
| 11 |
ACUTE MONOCYTIC LEUKAEMIA |
47 |
0.2582 |
| 12 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
235 |
0.2482 |
| 13 |
MYCOBACTERIUM CHELONAE INFECTION |
179 |
0.2422 |
| 14 |
DISSEMINATED ASPERGILLOSIS |
110 |
0.2331 |
| 15 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
497 |
0.2313 |
| 16 |
CONGENITAL APLASIA |
71 |
0.2283 |
| 17 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
502 |
0.2275 |
| 18 |
RETINOIC ACID SYNDROME |
39 |
0.2267 |
| 19 |
SECONDARY IMMUNODEFICIENCY |
263 |
0.2165 |
| 20 |
ABSCESS BACTERIAL |
76 |
0.2094 |
| 21 |
FUSARIUM INFECTION |
145 |
0.2071 |
| 22 |
ENTEROVIRUS TEST POSITIVE |
34 |
0.1954 |
| 23 |
MALIGNANT TRANSFORMATION |
86 |
0.1915 |
| 24 |
NEUTROPENIC COLITIS |
388 |
0.1874 |
| 25 |
ANTITHROMBIN III DECREASED |
48 |
0.1758 |
| 26 |
FEBRILE BONE MARROW APLASIA |
742 |
0.1744 |
| 27 |
HYPOFIBRINOGENAEMIA |
170 |
0.1714 |
| 28 |
PSEUDOMONAL SEPSIS |
298 |
0.1700 |
| 29 |
TREATMENT RELATED SECONDARY MALIGNANCY |
34 |
0.1675 |
| 30 |
CENTRAL HYPOTHYROIDISM |
55 |
0.1662 |
| 31 |
CHLOROMA |
70 |
0.1659 |
| 32 |
BLOOD STEM CELL TRANSPLANT FAILURE |
35 |
0.1628 |
| 33 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
37 |
0.1595 |
| 34 |
MYELOPATHY |
300 |
0.1578 |
| 35 |
CORONA VIRUS INFECTION |
67 |
0.1558 |
| 36 |
LEUKAEMIA RECURRENT |
263 |
0.1554 |
| 37 |
PARAINFLUENZAE VIRUS INFECTION |
235 |
0.1543 |
| 38 |
T-CELL TYPE ACUTE LEUKAEMIA |
31 |
0.1520 |
| 39 |
APLASIA |
290 |
0.1480 |
| 40 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
134 |
0.1449 |
| 41 |
VENOOCCLUSIVE LIVER DISEASE |
707 |
0.1430 |
| 42 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
364 |
0.1409 |
| 43 |
BLOOD CULTURE POSITIVE |
417 |
0.1391 |
| 44 |
TRICHOSPORON INFECTION |
55 |
0.1358 |
| 45 |
B-CELL LYMPHOMA RECURRENT |
72 |
0.1326 |
| 46 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
52 |
0.1323 |
| 47 |
ARACHNOIDITIS |
91 |
0.1315 |
| 48 |
HUMAN HERPESVIRUS 6 INFECTION |
244 |
0.1290 |
| 49 |
PYOMYOSITIS |
38 |
0.1284 |
| 50 |
VENOOCCLUSIVE DISEASE |
321 |
0.1281 |
| 51 |
ENTEROBACTER INFECTION |
213 |
0.1266 |
| 52 |
ASPERGILLUS TEST POSITIVE |
38 |
0.1234 |
| 53 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
47 |
0.1208 |
| 54 |
CEREBRAL FUNGAL INFECTION |
34 |
0.1201 |
| 55 |
FEBRILE NEUTROPENIA |
7783 |
0.1172 |
| 56 |
SYSTEMIC MYCOSIS |
136 |
0.1164 |
| 57 |
FUNGAEMIA |
181 |
0.1149 |
| 58 |
GLIOMA |
73 |
0.1135 |
| 59 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
37 |
0.1128 |
| 60 |
BACILLUS INFECTION |
71 |
0.1123 |
| 61 |
CYTOMEGALOVIRUS CHORIORETINITIS |
218 |
0.1117 |
| 62 |
KLEBSIELLA SEPSIS |
120 |
0.1065 |
| 63 |
MINIMAL RESIDUAL DISEASE |
51 |
0.1056 |
| 64 |
ESCHERICHIA BACTERAEMIA |
247 |
0.1050 |
| 65 |
ZYGOMYCOSIS |
49 |
0.1047 |
| 66 |
HUMAN RHINOVIRUS TEST POSITIVE |
39 |
0.1046 |
| 67 |
ENGRAFT FAILURE |
30 |
0.1045 |
| 68 |
VIRAL HAEMORRHAGIC CYSTITIS |
74 |
0.1039 |
| 69 |
ENGRAFTMENT SYNDROME |
61 |
0.1032 |
| 70 |
CYSTITIS VIRAL |
38 |
0.0992 |
| 71 |
LEUKOENCEPHALOPATHY |
369 |
0.0990 |
| 72 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
136 |
0.0986 |
| 73 |
ENTEROCOCCAL BACTERAEMIA |
104 |
0.0981 |
| 74 |
NEUTROPENIC INFECTION |
93 |
0.0972 |
| 75 |
CANDIDA PNEUMONIA |
31 |
0.0960 |
| 76 |
BRONCHOPULMONARY ASPERGILLOSIS |
741 |
0.0955 |
| 77 |
MANTLE CELL LYMPHOMA |
143 |
0.0939 |
| 78 |
PNEUMONIA FUNGAL |
370 |
0.0937 |
| 79 |
STREPTOCOCCAL BACTERAEMIA |
100 |
0.0919 |
| 80 |
ENTEROBACTER SEPSIS |
34 |
0.0919 |
| 81 |
VIRAEMIA |
127 |
0.0916 |
| 82 |
BLAST CELLS PRESENT |
44 |
0.0915 |
| 83 |
STENOTROPHOMONAS INFECTION |
124 |
0.0914 |
| 84 |
ENTEROCOCCUS TEST POSITIVE |
59 |
0.0910 |
| 85 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
59 |
0.0899 |
| 86 |
VASOGENIC CEREBRAL OEDEMA |
64 |
0.0889 |
| 87 |
GRANULOCYTE COUNT DECREASED |
164 |
0.0884 |
| 88 |
MUCORMYCOSIS |
228 |
0.0877 |
| 89 |
PSEUDOMONAL BACTERAEMIA |
74 |
0.0867 |
| 90 |
CENTRAL LINE INFECTION |
32 |
0.0865 |
| 91 |
MYELODYSPLASTIC SYNDROME TRANSFORMATION |
45 |
0.0864 |
| 92 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
237 |
0.0857 |
| 93 |
ACUTE MYELOID LEUKAEMIA |
1332 |
0.0854 |
| 94 |
BLOOD FIBRINOGEN DECREASED |
97 |
0.0849 |
| 95 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
61 |
0.0848 |
| 96 |
SINUSITIS FUNGAL |
67 |
0.0835 |
| 97 |
FOLLICULAR LYMPHOMA |
73 |
0.0830 |
| 98 |
CANDIDA SEPSIS |
74 |
0.0825 |
| 99 |
MYELOID LEUKAEMIA |
41 |
0.0818 |
| 100 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
38 |
0.0815 |
| 101 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
65 |
0.0814 |
| 102 |
HAEMATOTOXICITY |
771 |
0.0811 |
| 103 |
SYSTEMIC CANDIDA |
203 |
0.0808 |
| 104 |
METASTASES TO SPLEEN |
33 |
0.0799 |
| 105 |
B PRECURSOR TYPE ACUTE LEUKAEMIA |
31 |
0.0799 |
| 106 |
KLEBSIELLA TEST POSITIVE |
52 |
0.0799 |
| 107 |
DIFFUSE ALVEOLAR DAMAGE |
91 |
0.0791 |
| 108 |
PSEUDOMONAS TEST POSITIVE |
64 |
0.0781 |
| 109 |
ASPERGILLUS INFECTION |
508 |
0.0773 |
| 110 |
BACTERIAL SEPSIS |
252 |
0.0773 |
| 111 |
ESCHERICHIA SEPSIS |
224 |
0.0772 |
| 112 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
79 |
0.0768 |
| 113 |
DIFFERENTIATION SYNDROME |
56 |
0.0763 |
| 114 |
ASPERGILLOSIS |
97 |
0.0742 |
| 115 |
METASTASES TO BONE MARROW |
37 |
0.0740 |
| 116 |
ENTEROCOCCAL INFECTION |
355 |
0.0734 |
| 117 |
ENCEPHALITIS CYTOMEGALOVIRUS |
32 |
0.0731 |
| 118 |
ENTEROCOCCAL SEPSIS |
59 |
0.0728 |
| 119 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
206 |
0.0727 |
| 120 |
FUNGAL SEPSIS |
60 |
0.0722 |
| 121 |
RESPIRATORY TRACT INFECTION FUNGAL |
38 |
0.0720 |
| 122 |
STREPTOCOCCAL SEPSIS |
84 |
0.0708 |
| 123 |
SCEDOSPORIUM INFECTION |
50 |
0.0708 |
| 124 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
100 |
0.0708 |
| 125 |
MUCOSAL INFLAMMATION |
1846 |
0.0704 |
| 126 |
NEOPLASM RECURRENCE |
235 |
0.0692 |
| 127 |
TUMOUR LYSIS SYNDROME |
605 |
0.0687 |
| 128 |
DIFFUSE LARGE B-CELL LYMPHOMA |
529 |
0.0686 |
| 129 |
CYTOMEGALOVIRUS VIRAEMIA |
304 |
0.0683 |
| 130 |
STEROID DIABETES |
102 |
0.0680 |
| 131 |
NEUTROPENIC SEPSIS |
483 |
0.0676 |
| 132 |
MYELOSUPPRESSION |
2421 |
0.0671 |
| 133 |
GRAFT VERSUS HOST DISEASE IN LIVER |
48 |
0.0670 |
| 134 |
ENTEROVIRUS INFECTION |
57 |
0.0660 |
| 135 |
PNEUMATOSIS INTESTINALIS |
186 |
0.0651 |
| 136 |
GRAFT VERSUS HOST DISEASE IN SKIN |
143 |
0.0649 |
| 137 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
138 |
0.0648 |
| 138 |
MYELODYSPLASTIC SYNDROME |
915 |
0.0632 |
| 139 |
KLEBSIELLA BACTERAEMIA |
60 |
0.0632 |
| 140 |
RHINOVIRUS INFECTION |
246 |
0.0631 |
| 141 |
ESCHERICHIA TEST POSITIVE |
75 |
0.0626 |
| 142 |
ACUTE GRAFT VERSUS HOST DISEASE |
284 |
0.0620 |
| 143 |
BONE MARROW FAILURE |
1245 |
0.0612 |
| 144 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
79 |
0.0600 |
| 145 |
B-CELL TYPE ACUTE LEUKAEMIA |
44 |
0.0599 |
| 146 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
264 |
0.0597 |
| 147 |
DRUG CLEARANCE DECREASED |
78 |
0.0597 |
| 148 |
STEM CELL TRANSPLANT |
146 |
0.0584 |
| 149 |
STAPHYLOCOCCAL BACTERAEMIA |
253 |
0.0581 |
| 150 |
FEBRILE INFECTION |
68 |
0.0578 |
| 151 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
39 |
0.0575 |
| 152 |
CYSTITIS HAEMORRHAGIC |
231 |
0.0572 |
| 153 |
GLIOBLASTOMA MULTIFORME |
48 |
0.0570 |
| 154 |
CEREBRAL TOXOPLASMOSIS |
53 |
0.0567 |
| 155 |
SEPTIC EMBOLUS |
47 |
0.0565 |
| 156 |
PERIPHERAL MOTOR NEUROPATHY |
79 |
0.0563 |
| 157 |
ENTEROCOLITIS INFECTIOUS |
52 |
0.0563 |
| 158 |
CLOSTRIDIUM DIFFICILE COLITIS |
586 |
0.0552 |
| 159 |
PULMONARY MYCOSIS |
43 |
0.0552 |
| 160 |
GRAFT VERSUS HOST DISEASE |
395 |
0.0549 |
| 161 |
CHRONIC GRAFT VERSUS HOST DISEASE |
198 |
0.0548 |
| 162 |
HYPERBILIRUBINAEMIA |
567 |
0.0547 |
| 163 |
STAPHYLOCOCCAL SEPSIS |
269 |
0.0544 |
| 164 |
CAPILLARY LEAK SYNDROME |
112 |
0.0541 |
| 165 |
BACTERAEMIA |
640 |
0.0539 |
| 166 |
EPSTEIN-BARR VIRAEMIA |
59 |
0.0532 |
| 167 |
CONTINUOUS HAEMODIAFILTRATION |
51 |
0.0521 |
| 168 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
495 |
0.0518 |
| 169 |
SECOND PRIMARY MALIGNANCY |
425 |
0.0510 |
| 170 |
ADENOVIRUS INFECTION |
148 |
0.0510 |
| 171 |
HYPERTRIGLYCERIDAEMIA |
298 |
0.0509 |
| 172 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
47 |
0.0508 |
| 173 |
PHILADELPHIA CHROMOSOME POSITIVE |
36 |
0.0492 |
| 174 |
PNEUMONIA KLEBSIELLA |
90 |
0.0489 |
| 175 |
GASTROENTERITIS NOROVIRUS |
65 |
0.0489 |
| 176 |
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME |
38 |
0.0486 |
| 177 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
183 |
0.0479 |
| 178 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
34 |
0.0474 |
| 179 |
PNEUMONIA CYTOMEGALOVIRAL |
91 |
0.0468 |
| 180 |
HYPOGAMMAGLOBULINAEMIA |
307 |
0.0467 |
| 181 |
WHITE MATTER LESION |
58 |
0.0459 |
| 182 |
CLOSTRIDIUM TEST POSITIVE |
100 |
0.0453 |
| 183 |
JC VIRUS INFECTION |
72 |
0.0450 |
| 184 |
BLAST CELL COUNT INCREASED |
47 |
0.0448 |
| 185 |
CYTOPENIA |
546 |
0.0445 |
| 186 |
KLEBSIELLA INFECTION |
225 |
0.0444 |
| 187 |
CATHETER RELATED INFECTION |
45 |
0.0444 |
| 188 |
HISTIOCYTOSIS HAEMATOPHAGIC |
131 |
0.0441 |
| 189 |
TOXIC LEUKOENCEPHALOPATHY |
32 |
0.0441 |
| 190 |
SEPTIC SHOCK |
1909 |
0.0438 |
| 191 |
SOFT TISSUE INFECTION |
80 |
0.0437 |
| 192 |
CSF PROTEIN INCREASED |
35 |
0.0422 |
| 193 |
PHARYNGEAL INFLAMMATION |
51 |
0.0419 |
| 194 |
PLATELET TRANSFUSION |
54 |
0.0419 |
| 195 |
NEUROTOXICITY |
733 |
0.0418 |
| 196 |
HYPERLEUKOCYTOSIS |
37 |
0.0418 |
| 197 |
BACTERIAL INFECTION |
770 |
0.0412 |
| 198 |
TRANSFUSION REACTION |
36 |
0.0410 |
| 199 |
CEREBELLAR SYNDROME |
90 |
0.0410 |
| 200 |
INTUSSUSCEPTION |
39 |
0.0408 |
| 201 |
DEVICE RELATED THROMBOSIS |
40 |
0.0406 |
| 202 |
PULMONARY HAEMORRHAGE |
313 |
0.0400 |
| 203 |
VENOUS THROMBOSIS |
157 |
0.0400 |
| 204 |
BONE MARROW DEPRESSION |
39 |
0.0400 |
| 205 |
CYTOGENETIC ABNORMALITY |
45 |
0.0399 |
| 206 |
CULTURE POSITIVE |
33 |
0.0395 |
| 207 |
PANCYTOPENIA |
2200 |
0.0393 |
| 208 |
CEREBRAL VENOUS SINUS THROMBOSIS |
33 |
0.0391 |
| 209 |
GENE MUTATION |
77 |
0.0389 |
| 210 |
PROCALCITONIN INCREASED |
45 |
0.0383 |
| 211 |
PSEUDOMONAS INFECTION |
329 |
0.0383 |
| 212 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
32 |
0.0380 |
| 213 |
QUADRIPARESIS |
63 |
0.0379 |
| 214 |
ENTERITIS |
240 |
0.0375 |
| 215 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
222 |
0.0374 |
| 216 |
BK VIRUS INFECTION |
124 |
0.0367 |
| 217 |
ESCHERICHIA INFECTION |
302 |
0.0367 |
| 218 |
CLOSTRIDIUM COLITIS |
44 |
0.0362 |
| 219 |
PERIRECTAL ABSCESS |
40 |
0.0361 |
| 220 |
PARAPLEGIA |
104 |
0.0360 |
| 221 |
HERPES SIMPLEX |
231 |
0.0355 |
| 222 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
180 |
0.0353 |
| 223 |
CYTOKINE RELEASE SYNDROME |
703 |
0.0350 |
| 224 |
MENINGITIS BACTERIAL |
50 |
0.0349 |
| 225 |
CENTRAL NERVOUS SYSTEM INFECTION |
40 |
0.0349 |
| 226 |
ENTEROCOLITIS |
200 |
0.0346 |
| 227 |
STAPHYLOCOCCUS TEST POSITIVE |
72 |
0.0341 |
| 228 |
BLAST CRISIS IN MYELOGENOUS LEUKAEMIA |
42 |
0.0340 |
| 229 |
OESOPHAGEAL CANDIDIASIS |
135 |
0.0338 |
| 230 |
CARDIOTOXICITY |
301 |
0.0337 |
| 231 |
GASTROINTESTINAL TOXICITY |
161 |
0.0335 |
| 232 |
INFECTION REACTIVATION |
38 |
0.0332 |
| 233 |
PARAPARESIS |
59 |
0.0331 |
| 234 |
LUNG CONSOLIDATION |
92 |
0.0329 |
| 235 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
58 |
0.0328 |
| 236 |
JUGULAR VEIN THROMBOSIS |
58 |
0.0326 |
| 237 |
SUBCLAVIAN VEIN THROMBOSIS |
37 |
0.0325 |
| 238 |
LUNG INFILTRATION |
287 |
0.0325 |
| 239 |
HEPATITIS B REACTIVATION |
103 |
0.0324 |
| 240 |
TOXOPLASMOSIS |
35 |
0.0324 |
| 241 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
513 |
0.0323 |
| 242 |
HEPATOSPLENOMEGALY |
82 |
0.0319 |
| 243 |
VENA CAVA THROMBOSIS |
53 |
0.0319 |
| 244 |
SKIN TOXICITY |
180 |
0.0318 |
| 245 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
881 |
0.0311 |
| 246 |
MULTIPLE-DRUG RESISTANCE |
96 |
0.0309 |
| 247 |
APLASTIC ANAEMIA |
161 |
0.0308 |
| 248 |
HYPOALBUMINAEMIA |
239 |
0.0307 |
| 249 |
NEUROLOGICAL DECOMPENSATION |
71 |
0.0307 |
| 250 |
CYTOMEGALOVIRUS INFECTION |
507 |
0.0305 |
| 251 |
EPSTEIN-BARR VIRUS INFECTION |
190 |
0.0304 |
| 252 |
HEPATITIS E |
48 |
0.0304 |
| 253 |
ACINETOBACTER INFECTION |
33 |
0.0301 |
| 254 |
DYSPLASIA |
36 |
0.0300 |
| 255 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
529 |
0.0299 |
| 256 |
BONE MARROW DISORDER |
90 |
0.0298 |
| 257 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
222 |
0.0296 |
| 258 |
GASTROINTESTINAL WALL THICKENING |
44 |
0.0294 |
| 259 |
AREFLEXIA |
78 |
0.0292 |
| 260 |
CEREBRAL VENOUS THROMBOSIS |
53 |
0.0292 |
| 261 |
CYTOMEGALOVIRUS TEST POSITIVE |
52 |
0.0291 |
| 262 |
QUADRIPLEGIA |
60 |
0.0291 |
| 263 |
BRAIN HERNIATION |
87 |
0.0291 |
| 264 |
HAEMATOLOGICAL INFECTION |
71 |
0.0290 |
| 265 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
31 |
0.0289 |
| 266 |
GASTROINTESTINAL NECROSIS |
83 |
0.0284 |
| 267 |
BILIRUBIN CONJUGATED INCREASED |
66 |
0.0282 |
| 268 |
CULTURE URINE POSITIVE |
39 |
0.0277 |
| 269 |
NEUTROPENIA |
3744 |
0.0275 |
| 270 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
63 |
0.0271 |
| 271 |
THROMBOCYTOPENIA |
3005 |
0.0268 |
| 272 |
SEPSIS |
2989 |
0.0268 |
| 273 |
MULTI-ORGAN FAILURE |
458 |
0.0265 |
| 274 |
BACTERIAL TEST POSITIVE |
59 |
0.0264 |
| 275 |
DISSEMINATED INTRAVASCULAR COAGULATION |
370 |
0.0263 |
| 276 |
ACUTE LEUKAEMIA |
42 |
0.0260 |
| 277 |
PERIPHERAL SENSORY NEUROPATHY |
151 |
0.0258 |
| 278 |
ENCEPHALITIS |
178 |
0.0257 |
| 279 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
258 |
0.0257 |
| 280 |
PUPIL FIXED |
44 |
0.0254 |
| 281 |
BONE MARROW TRANSPLANT |
48 |
0.0253 |
| 282 |
NEUTROPHIL COUNT DECREASED |
1030 |
0.0252 |
| 283 |
CYTOMEGALOVIRUS COLITIS |
58 |
0.0252 |
| 284 |
THERAPY PARTIAL RESPONDER |
389 |
0.0249 |
| 285 |
DEVICE RELATED SEPSIS |
50 |
0.0248 |
| 286 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
203 |
0.0246 |
| 287 |
NEPHROPATHY TOXIC |
276 |
0.0246 |
| 288 |
MYELITIS |
38 |
0.0245 |
| 289 |
HEPATOTOXICITY |
545 |
0.0245 |
| 290 |
BRAIN ABSCESS |
61 |
0.0241 |
| 291 |
LEFT VENTRICULAR DYSFUNCTION |
161 |
0.0240 |
| 292 |
BLOOD BILIRUBIN INCREASED |
642 |
0.0237 |
| 293 |
METASTASES TO MENINGES |
54 |
0.0237 |
| 294 |
HYPOPROTEINAEMIA |
45 |
0.0237 |
| 295 |
DISEASE PROGRESSION |
2800 |
0.0236 |
| 296 |
OBLITERATIVE BRONCHIOLITIS |
31 |
0.0236 |
| 297 |
GUILLAIN-BARRE SYNDROME |
114 |
0.0235 |
| 298 |
LYMPHOPENIA |
329 |
0.0232 |
| 299 |
MEGACOLON |
36 |
0.0229 |
| 300 |
PNEUMONIA PSEUDOMONAL |
35 |
0.0228 |
| 301 |
CLOSTRIDIAL INFECTION |
77 |
0.0227 |
| 302 |
VARICELLA ZOSTER VIRUS INFECTION |
47 |
0.0227 |
| 303 |
FUNGAL INFECTION |
754 |
0.0226 |
| 304 |
VENTRICULAR HYPOKINESIA |
72 |
0.0224 |
| 305 |
OTOTOXICITY |
41 |
0.0222 |
| 306 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
32 |
0.0220 |
| 307 |
PULMONARY ALVEOLAR HAEMORRHAGE |
123 |
0.0219 |
| 308 |
AGRANULOCYTOSIS |
405 |
0.0218 |
| 309 |
DEVICE RELATED INFECTION |
330 |
0.0214 |
| 310 |
HYPERPHOSPHATAEMIA |
46 |
0.0214 |
| 311 |
SPINAL CORD DISORDER |
35 |
0.0213 |
| 312 |
CANDIDA INFECTION |
347 |
0.0205 |
| 313 |
HYPERPYREXIA |
86 |
0.0203 |
| 314 |
LYMPHOMA |
312 |
0.0202 |
| 315 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
102 |
0.0201 |
| 316 |
ENCEPHALOPATHY |
491 |
0.0200 |
| 317 |
HAEMODYNAMIC INSTABILITY |
152 |
0.0199 |
| 318 |
ILEUS PARALYTIC |
89 |
0.0199 |
| 319 |
COLITIS |
748 |
0.0197 |
| 320 |
B-CELL LYMPHOMA |
66 |
0.0194 |
| 321 |
RADICULOPATHY |
51 |
0.0193 |
| 322 |
MULTI-ORGAN DISORDER |
38 |
0.0193 |
| 323 |
ATELECTASIS |
186 |
0.0192 |
| 324 |
INTRACARDIAC THROMBUS |
59 |
0.0192 |
| 325 |
PATHOGEN RESISTANCE |
174 |
0.0191 |
| 326 |
INTRACRANIAL PRESSURE INCREASED |
105 |
0.0188 |
| 327 |
HEPATITIS B |
113 |
0.0187 |
| 328 |
CANDIDIASIS |
75 |
0.0187 |
| 329 |
HEPATOMEGALY |
182 |
0.0185 |
| 330 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
41 |
0.0184 |
| 331 |
NEUTROPHIL COUNT ABNORMAL |
52 |
0.0184 |
| 332 |
RECURRENT CANCER |
73 |
0.0179 |
| 333 |
LUNG OPACITY |
47 |
0.0178 |
| 334 |
NEOPLASM PROGRESSION |
618 |
0.0178 |
| 335 |
HYPOREFLEXIA |
34 |
0.0177 |
| 336 |
BLOOD HIV RNA INCREASED |
32 |
0.0176 |
| 337 |
RESPIRATORY FAILURE |
1283 |
0.0176 |
| 338 |
PNEUMONIA VIRAL |
56 |
0.0175 |
| 339 |
HYPOXIA |
616 |
0.0175 |
| 340 |
HAEMOGLOBIN ABNORMAL |
112 |
0.0174 |
| 341 |
HAEMODIALYSIS |
146 |
0.0174 |
| 342 |
NECROTISING FASCIITIS |
61 |
0.0173 |
| 343 |
RESPIRATORY DISTRESS |
477 |
0.0173 |
| 344 |
LIVER ABSCESS |
56 |
0.0172 |
| 345 |
EJECTION FRACTION DECREASED |
268 |
0.0172 |
| 346 |
THROMBOTIC MICROANGIOPATHY |
167 |
0.0171 |
| 347 |
LUNG NEOPLASM |
73 |
0.0171 |
| 348 |
HYDROCEPHALUS |
93 |
0.0171 |
| 349 |
ATYPICAL PNEUMONIA |
51 |
0.0170 |
| 350 |
STAPHYLOCOCCAL INFECTION |
561 |
0.0170 |
| 351 |
TACHYPNOEA |
231 |
0.0170 |
| 352 |
CARDIOMYOPATHY |
248 |
0.0168 |
| 353 |
COAGULOPATHY |
278 |
0.0167 |
| 354 |
MONOPARESIS |
30 |
0.0166 |
| 355 |
HEPATIC LESION |
71 |
0.0164 |
| 356 |
CARDIAC DYSFUNCTION |
61 |
0.0164 |
| 357 |
ACIDOSIS |
125 |
0.0163 |
| 358 |
TRANSPLANT FAILURE |
40 |
0.0163 |
| 359 |
PLATELET COUNT DECREASED |
1739 |
0.0163 |
| 360 |
GRANULOCYTOPENIA |
92 |
0.0161 |
| 361 |
HYPERURICAEMIA |
66 |
0.0160 |
| 362 |
ILEUS |
197 |
0.0158 |
| 363 |
STREPTOCOCCAL INFECTION |
88 |
0.0158 |
| 364 |
LYMPHOCYTOSIS |
34 |
0.0158 |
| 365 |
LIPASE INCREASED |
121 |
0.0158 |
| 366 |
PULSE ABSENT |
75 |
0.0158 |
| 367 |
SUBDURAL HAEMORRHAGE |
43 |
0.0157 |
| 368 |
POLYNEUROPATHY |
188 |
0.0157 |
| 369 |
PETECHIAE |
163 |
0.0156 |
| 370 |
RETINAL HAEMORRHAGE |
111 |
0.0156 |
| 371 |
INTRA-ABDOMINAL HAEMORRHAGE |
37 |
0.0155 |
| 372 |
PLATELET DISORDER |
39 |
0.0155 |
| 373 |
DRUG RESISTANCE |
396 |
0.0154 |
| 374 |
SUBILEUS |
32 |
0.0154 |
| 375 |
HYPOPHOSPHATAEMIA |
113 |
0.0153 |
| 376 |
SINUS TACHYCARDIA |
216 |
0.0152 |
| 377 |
APPENDICITIS |
142 |
0.0152 |
| 378 |
LEUKOPENIA |
758 |
0.0151 |
| 379 |
LUNG INFECTION |
232 |
0.0149 |
| 380 |
ABDOMINAL INFECTION |
38 |
0.0149 |
| 381 |
PARESIS |
33 |
0.0148 |
| 382 |
BLOOD LACTIC ACID INCREASED |
78 |
0.0148 |
| 383 |
PANCREATITIS NECROTISING |
34 |
0.0148 |
| 384 |
HAEMORRHAGE INTRACRANIAL |
220 |
0.0147 |
| 385 |
HYPERNATRAEMIA |
73 |
0.0146 |
| 386 |
COMPUTERISED TOMOGRAM ABNORMAL |
33 |
0.0146 |
| 387 |
PLATELET COUNT ABNORMAL |
88 |
0.0145 |
| 388 |
NEUROLOGICAL SYMPTOM |
83 |
0.0145 |
| 389 |
CYTOLYTIC HEPATITIS |
48 |
0.0144 |
| 390 |
PLEURAL EFFUSION |
873 |
0.0143 |
| 391 |
CHRONIC MYELOID LEUKAEMIA |
66 |
0.0143 |
| 392 |
PNEUMONIA BACTERIAL |
131 |
0.0143 |
| 393 |
MENINGITIS ASEPTIC |
64 |
0.0142 |
| 394 |
BLOOD ALBUMIN DECREASED |
113 |
0.0142 |
| 395 |
WHITE BLOOD CELL DISORDER |
38 |
0.0142 |
| 396 |
TRANSAMINASES INCREASED |
315 |
0.0142 |
| 397 |
CARDIAC TAMPONADE |
67 |
0.0141 |
| 398 |
NECROSIS |
78 |
0.0140 |
| 399 |
ALANINE AMINOTRANSFERASE INCREASED |
855 |
0.0139 |
| 400 |
METHAEMOGLOBINAEMIA |
32 |
0.0138 |
| 401 |
HYPERAMMONAEMIA |
69 |
0.0138 |
| 402 |
BRAIN OEDEMA |
173 |
0.0137 |
| 403 |
ASCITES |
402 |
0.0137 |
| 404 |
TOXIC ENCEPHALOPATHY |
69 |
0.0136 |
| 405 |
MYELOFIBROSIS |
41 |
0.0135 |
| 406 |
ORGANISING PNEUMONIA |
67 |
0.0135 |
| 407 |
HEPATOCELLULAR INJURY |
190 |
0.0134 |
| 408 |
PROTHROMBIN TIME PROLONGED |
80 |
0.0134 |
| 409 |
ACUTE PULMONARY OEDEMA |
75 |
0.0133 |
| 410 |
PERICARDIAL EFFUSION |
308 |
0.0133 |
| 411 |
WHITE BLOOD CELL COUNT ABNORMAL |
85 |
0.0133 |
| 412 |
PULMONARY TOXICITY |
94 |
0.0133 |
| 413 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
136 |
0.0132 |
| 414 |
CARDIAC FAILURE ACUTE |
88 |
0.0132 |
| 415 |
INFECTION |
1897 |
0.0131 |
| 416 |
HYPERTRANSAMINASAEMIA |
91 |
0.0131 |
| 417 |
SUBDURAL HAEMATOMA |
187 |
0.0131 |
| 418 |
ELECTROLYTE IMBALANCE |
151 |
0.0130 |
| 419 |
PORTAL HYPERTENSION |
40 |
0.0130 |
| 420 |
STOMATITIS |
786 |
0.0129 |
| 421 |
SUBARACHNOID HAEMORRHAGE |
131 |
0.0128 |
| 422 |
PAPILLOEDEMA |
58 |
0.0128 |
| 423 |
HEMIPARESIS |
217 |
0.0128 |
| 424 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
34 |
0.0128 |
| 425 |
MENINGITIS |
85 |
0.0127 |
| 426 |
ENDOCARDITIS |
65 |
0.0127 |
| 427 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
63 |
0.0126 |
| 428 |
HEPATIC FAILURE |
379 |
0.0126 |
| 429 |
OLIGURIA |
78 |
0.0126 |
| 430 |
SERUM FERRITIN INCREASED |
66 |
0.0125 |
| 431 |
HYPOKALAEMIA |
577 |
0.0125 |
| 432 |
ATAXIA |
148 |
0.0125 |
| 433 |
TACHYARRHYTHMIA |
31 |
0.0124 |
| 434 |
LYMPHADENITIS |
30 |
0.0124 |
| 435 |
WHITE BLOOD CELL COUNT DECREASED |
1342 |
0.0124 |
| 436 |
ASPARTATE AMINOTRANSFERASE INCREASED |
657 |
0.0124 |
| 437 |
PYREXIA |
4271 |
0.0123 |
| 438 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
42 |
0.0122 |
| 439 |
AMYLASE INCREASED |
45 |
0.0122 |
| 440 |
CHOLESTASIS |
233 |
0.0121 |
| 441 |
GASTROINTESTINAL INFLAMMATION |
95 |
0.0121 |
| 442 |
CARDIOPULMONARY FAILURE |
47 |
0.0120 |
| 443 |
METABOLIC DISORDER |
70 |
0.0120 |
| 444 |
EMBOLISM |
100 |
0.0120 |
| 445 |
ABDOMINAL MASS |
32 |
0.0119 |
| 446 |
HYPOVOLAEMIC SHOCK |
57 |
0.0119 |
| 447 |
HYDRONEPHROSIS |
89 |
0.0119 |
| 448 |
FIBRIN D DIMER INCREASED |
42 |
0.0118 |
| 449 |
OTITIS MEDIA |
39 |
0.0118 |
| 450 |
LEUKAEMIA |
111 |
0.0118 |
| 451 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
257 |
0.0116 |
| 452 |
NO THERAPEUTIC RESPONSE |
141 |
0.0116 |
| 453 |
ANAL ABSCESS |
62 |
0.0115 |
| 454 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
100 |
0.0115 |
| 455 |
VASCULAR DEVICE INFECTION |
52 |
0.0115 |
| 456 |
HEPATITIS FULMINANT |
34 |
0.0114 |
| 457 |
ARTHRITIS BACTERIAL |
47 |
0.0114 |
| 458 |
ELECTROENCEPHALOGRAM ABNORMAL |
36 |
0.0114 |
| 459 |
LYMPHADENOPATHY |
402 |
0.0113 |
| 460 |
BRAIN DEATH |
35 |
0.0113 |
| 461 |
FACIAL PARESIS |
40 |
0.0113 |
| 462 |
HAEMORRHAGE SUBCUTANEOUS |
40 |
0.0113 |
| 463 |
FLUID OVERLOAD |
164 |
0.0113 |
| 464 |
ACUTE RESPIRATORY FAILURE |
215 |
0.0112 |
| 465 |
THERAPY NON-RESPONDER |
500 |
0.0111 |
| 466 |
ANURIA |
95 |
0.0110 |
| 467 |
IMMUNOSUPPRESSION |
97 |
0.0110 |
| 468 |
DISEASE RECURRENCE |
521 |
0.0109 |
| 469 |
VIRAL INFECTION |
364 |
0.0109 |
| 470 |
HERPES VIRUS INFECTION |
63 |
0.0109 |
| 471 |
SPLENOMEGALY |
128 |
0.0109 |
| 472 |
CEREBRAL ISCHAEMIA |
56 |
0.0109 |
| 473 |
EMBOLISM VENOUS |
33 |
0.0109 |
| 474 |
SUSPECTED OFF LABEL USE |
49 |
0.0108 |
| 475 |
ESCHERICHIA URINARY TRACT INFECTION |
46 |
0.0108 |
| 476 |
MENTAL STATUS CHANGES |
300 |
0.0108 |
| 477 |
CHEST X-RAY ABNORMAL |
33 |
0.0108 |
| 478 |
TORSADE DE POINTES |
84 |
0.0107 |
| 479 |
HYPERGLYCAEMIA |
386 |
0.0106 |
| 480 |
CONGESTIVE CARDIOMYOPATHY |
44 |
0.0105 |
| 481 |
HEPATIC FUNCTION ABNORMAL |
389 |
0.0104 |
| 482 |
CHRONIC SINUSITIS |
39 |
0.0104 |
| 483 |
CLOSTRIDIUM DIFFICILE INFECTION |
226 |
0.0103 |
| 484 |
INTESTINAL ISCHAEMIA |
57 |
0.0103 |
| 485 |
FACIAL PARALYSIS |
87 |
0.0102 |
| 486 |
LEFT VENTRICULAR FAILURE |
35 |
0.0102 |
| 487 |
COVID-19 PNEUMONIA |
120 |
0.0102 |
| 488 |
CEREBRAL ATROPHY |
40 |
0.0100 |
| 489 |
DRUG TOXICITY |
136 |
0.0100 |
| 490 |
DRUG-INDUCED LIVER INJURY |
313 |
0.0100 |
| 491 |
ANAEMIA |
1894 |
0.0099 |
| 492 |
JAUNDICE CHOLESTATIC |
35 |
0.0099 |
| 493 |
ABSCESS LIMB |
42 |
0.0098 |
| 494 |
VIITH NERVE PARALYSIS |
34 |
0.0098 |
| 495 |
HYPOCALCAEMIA |
185 |
0.0098 |
| 496 |
LYMPHOCYTE COUNT DECREASED |
172 |
0.0097 |
| 497 |
HEPATIC CYTOLYSIS |
124 |
0.0097 |
| 498 |
GENERALISED OEDEMA |
120 |
0.0097 |
| 499 |
CHOLECYSTITIS |
115 |
0.0096 |
| 500 |
PROCTALGIA |
62 |
0.0096 |
| 501 |
RASH MACULO-PAPULAR |
214 |
0.0096 |
| 502 |
CEREBRAL HAEMORRHAGE |
344 |
0.0096 |
| 503 |
CELLULITIS |
484 |
0.0096 |
| 504 |
HYPOVOLAEMIA |
56 |
0.0096 |
| 505 |
PANCREATITIS ACUTE |
215 |
0.0096 |
| 506 |
PROTEIN TOTAL DECREASED |
36 |
0.0096 |
| 507 |
MOUTH HAEMORRHAGE |
70 |
0.0095 |
| 508 |
PULMONARY OEDEMA |
426 |
0.0095 |
| 509 |
PULMONARY MASS |
140 |
0.0094 |
| 510 |
ADRENAL INSUFFICIENCY |
114 |
0.0094 |
| 511 |
NERVOUS SYSTEM DISORDER |
292 |
0.0093 |
| 512 |
TOXIC EPIDERMAL NECROLYSIS |
141 |
0.0093 |
| 513 |
RENAL FAILURE ACUTE |
393 |
0.0093 |
| 514 |
DERMATITIS BULLOUS |
67 |
0.0092 |
| 515 |
CATHETER SITE INFECTION |
35 |
0.0092 |
| 516 |
FOETAL GROWTH RESTRICTION |
56 |
0.0092 |
| 517 |
MALIGNANT NEOPLASM PROGRESSION |
941 |
0.0092 |
| 518 |
TACHYCARDIA |
811 |
0.0091 |
| 519 |
HYPERVOLAEMIA |
45 |
0.0091 |
| 520 |
INFLAMMATORY MARKER INCREASED |
45 |
0.0091 |
| 521 |
URINE OUTPUT DECREASED |
79 |
0.0090 |
| 522 |
MYOSITIS |
81 |
0.0090 |
| 523 |
ORAL HERPES |
173 |
0.0089 |
| 524 |
ABDOMINAL TENDERNESS |
44 |
0.0089 |
| 525 |
DIALYSIS |
125 |
0.0088 |
| 526 |
FLUID INTAKE REDUCED |
44 |
0.0088 |
| 527 |
MONOPLEGIA |
38 |
0.0087 |
| 528 |
SHOCK HAEMORRHAGIC |
71 |
0.0087 |
| 529 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
203 |
0.0087 |
| 530 |
METASTASIS |
62 |
0.0087 |
| 531 |
ECCHYMOSIS |
59 |
0.0086 |
| 532 |
BODY TEMPERATURE INCREASED |
175 |
0.0086 |
| 533 |
INTESTINAL PERFORATION |
96 |
0.0085 |
| 534 |
TOXIC SKIN ERUPTION |
86 |
0.0085 |
| 535 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
63 |
0.0085 |
| 536 |
HAEMOGLOBIN DECREASED |
874 |
0.0085 |
| 537 |
C-REACTIVE PROTEIN INCREASED |
308 |
0.0085 |
| 538 |
ACUTE HEPATIC FAILURE |
115 |
0.0084 |
| 539 |
LARGE INTESTINE PERFORATION |
58 |
0.0083 |
| 540 |
LIVER INJURY |
203 |
0.0083 |
| 541 |
ACUTE KIDNEY INJURY |
1259 |
0.0082 |
| 542 |
RESPIRATORY RATE INCREASED |
73 |
0.0082 |
| 543 |
FUNGAL SKIN INFECTION |
33 |
0.0082 |
| 544 |
RENAL TUBULAR NECROSIS |
80 |
0.0081 |
| 545 |
SHOCK |
187 |
0.0081 |
| 546 |
LEUKOCYTOSIS |
147 |
0.0081 |
| 547 |
PNEUMONITIS |
221 |
0.0081 |
| 548 |
NEUROPATHY PERIPHERAL |
770 |
0.0081 |
| 549 |
BLOOD URIC ACID INCREASED |
46 |
0.0080 |
| 550 |
HEPATIC NECROSIS |
30 |
0.0080 |
| 551 |
CHOLECYSTITIS ACUTE |
45 |
0.0079 |
| 552 |
PULSELESS ELECTRICAL ACTIVITY |
33 |
0.0079 |
| 553 |
DISEASE COMPLICATION |
36 |
0.0079 |
| 554 |
TEMPERATURE INTOLERANCE |
81 |
0.0078 |
| 555 |
VENTRICULAR FIBRILLATION |
87 |
0.0078 |
| 556 |
HYPOMAGNESAEMIA |
109 |
0.0078 |
| 557 |
OSTEONECROSIS |
257 |
0.0078 |
| 558 |
PURPURA |
69 |
0.0078 |
| 559 |
DERMATITIS EXFOLIATIVE |
39 |
0.0078 |
| 560 |
STATUS EPILEPTICUS |
88 |
0.0078 |
| 561 |
MALNUTRITION |
87 |
0.0078 |
| 562 |
UNRESPONSIVE TO STIMULI |
200 |
0.0077 |
| 563 |
HEPATIC STEATOSIS |
144 |
0.0077 |
| 564 |
CACHEXIA |
39 |
0.0076 |
| 565 |
CARDIOGENIC SHOCK |
108 |
0.0075 |
| 566 |
SMALL INTESTINAL OBSTRUCTION |
92 |
0.0075 |
| 567 |
CORONAVIRUS INFECTION |
49 |
0.0074 |
| 568 |
HYPOTENSION |
1486 |
0.0074 |
| 569 |
PNEUMONIA |
2390 |
0.0074 |
| 570 |
HYPERTHERMIA |
56 |
0.0073 |
| 571 |
FAECAL INCONTINENCE |
35 |
0.0073 |
| 572 |
TRANSFUSION |
76 |
0.0072 |
| 573 |
PRODUCT USE IN UNAPPROVED INDICATION |
1793 |
0.0072 |
| 574 |
VENTRICULAR TACHYCARDIA |
119 |
0.0072 |
| 575 |
ODYNOPHAGIA |
43 |
0.0072 |
| 576 |
FULL BLOOD COUNT DECREASED |
145 |
0.0072 |
| 577 |
HYPOPHAGIA |
183 |
0.0072 |
| 578 |
SUPRAVENTRICULAR TACHYCARDIA |
68 |
0.0071 |
| 579 |
CENTRAL NERVOUS SYSTEM LESION |
96 |
0.0070 |
| 580 |
HEMIPLEGIA |
58 |
0.0070 |
| 581 |
HEPATIC ENCEPHALOPATHY |
65 |
0.0070 |
| 582 |
HEPATITIS ACUTE |
45 |
0.0069 |
| 583 |
HIDRADENITIS |
63 |
0.0069 |
| 584 |
PANCREATITIS |
365 |
0.0069 |
| 585 |
AMMONIA INCREASED |
35 |
0.0069 |
| 586 |
NEPHROTIC SYNDROME |
47 |
0.0068 |
| 587 |
BLOOD CREATININE INCREASED |
446 |
0.0068 |
| 588 |
DRUG ERUPTION |
121 |
0.0068 |
| 589 |
LOW BIRTH WEIGHT BABY |
54 |
0.0068 |
| 590 |
BLOOD CREATINE INCREASED |
30 |
0.0068 |
| 591 |
OESOPHAGITIS |
74 |
0.0068 |
| 592 |
HYPERCALCAEMIA |
83 |
0.0067 |
| 593 |
ELECTROCARDIOGRAM QT PROLONGED |
240 |
0.0067 |
| 594 |
GRAND MAL CONVULSION |
61 |
0.0066 |
| 595 |
CARDIAC FAILURE |
528 |
0.0066 |
| 596 |
BLOOD UREA INCREASED |
110 |
0.0066 |
| 597 |
SKIN NECROSIS |
34 |
0.0065 |
| 598 |
HICCUPS |
53 |
0.0065 |
| 599 |
ORAL DISORDER |
47 |
0.0064 |
| 600 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
158 |
0.0064 |
| 601 |
RESPIRATORY DISORDER |
190 |
0.0063 |
| 602 |
GENERALISED TONIC-CLONIC SEIZURE |
105 |
0.0063 |
| 603 |
RENAL FAILURE |
842 |
0.0063 |
| 604 |
SENSORY LOSS |
51 |
0.0063 |
| 605 |
IMMUNODEFICIENCY |
94 |
0.0063 |
| 606 |
APHASIA |
190 |
0.0063 |
| 607 |
JAUNDICE |
169 |
0.0063 |
| 608 |
PERICARDITIS |
105 |
0.0062 |
| 609 |
GASTROINTESTINAL INFECTION |
56 |
0.0062 |
| 610 |
RALES |
36 |
0.0062 |
| 611 |
PARTIAL SEIZURES |
32 |
0.0061 |
| 612 |
BRAIN NEOPLASM |
56 |
0.0061 |
| 613 |
DYSARTHRIA |
229 |
0.0061 |
| 614 |
SKIN INFECTION |
68 |
0.0061 |
| 615 |
CARDIO-RESPIRATORY ARREST |
253 |
0.0060 |
| 616 |
MYOPATHY |
52 |
0.0060 |
| 617 |
MYOCARDITIS |
69 |
0.0060 |
| 618 |
ATRIAL FLUTTER |
48 |
0.0060 |
| 619 |
NEOPLASM |
69 |
0.0060 |
| 620 |
OFF LABEL USE |
5221 |
0.0060 |
| 621 |
HAEMATOCRIT DECREASED |
118 |
0.0059 |
| 622 |
CARDIAC ARREST |
491 |
0.0059 |
| 623 |
TONSILLITIS |
31 |
0.0059 |
| 624 |
PNEUMOTHORAX |
94 |
0.0059 |
| 625 |
TROPONIN INCREASED |
45 |
0.0059 |
| 626 |
HYPONATRAEMIA |
333 |
0.0059 |
| 627 |
APNOEA |
46 |
0.0059 |
| 628 |
ANGIOPATHY |
33 |
0.0059 |
| 629 |
NYSTAGMUS |
31 |
0.0058 |
| 630 |
PERONEAL NERVE PALSY |
33 |
0.0058 |
| 631 |
TRICUSPID VALVE INCOMPETENCE |
46 |
0.0058 |
| 632 |
HAEMOLYSIS |
44 |
0.0057 |
| 633 |
ORAL CANDIDIASIS |
75 |
0.0057 |
| 634 |
SINUS BRADYCARDIA |
55 |
0.0057 |
| 635 |
VENTRICULAR EXTRASYSTOLES |
59 |
0.0057 |
| 636 |
BLOOD DISORDER |
45 |
0.0056 |
| 637 |
RESPIRATORY TRACT INFECTION |
146 |
0.0056 |
| 638 |
HEPATITIS |
142 |
0.0055 |
| 639 |
PAPULE |
39 |
0.0055 |
| 640 |
REFUSAL OF TREATMENT BY PATIENT |
36 |
0.0055 |
| 641 |
HAEMATURIA |
188 |
0.0055 |
| 642 |
HEPATITIS CHOLESTATIC |
33 |
0.0055 |
| 643 |
DIARRHOEA HAEMORRHAGIC |
51 |
0.0055 |
| 644 |
SKIN LESION |
149 |
0.0054 |
| 645 |
MITRAL VALVE INCOMPETENCE |
61 |
0.0054 |
| 646 |
METABOLIC ACIDOSIS |
172 |
0.0054 |
| 647 |
CHILLS |
630 |
0.0054 |
| 648 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
211 |
0.0053 |
| 649 |
MOUTH ULCERATION |
112 |
0.0053 |
| 650 |
ANOREXIA |
68 |
0.0053 |
| 651 |
EYE MOVEMENT DISORDER |
36 |
0.0053 |
| 652 |
DERMATITIS ALLERGIC |
66 |
0.0052 |
| 653 |
SKIN MASS |
35 |
0.0052 |
| 654 |
NEUTROPHIL COUNT INCREASED |
53 |
0.0052 |
| 655 |
ENDOPHTHALMITIS |
31 |
0.0052 |
| 656 |
RENAL IMPAIRMENT |
434 |
0.0052 |
| 657 |
PREMATURE DELIVERY |
82 |
0.0051 |
| 658 |
MOTOR DYSFUNCTION |
52 |
0.0051 |
| 659 |
BLOOD CALCIUM DECREASED |
57 |
0.0051 |
| 660 |
TOXICITY TO VARIOUS AGENTS |
848 |
0.0050 |
| 661 |
HAEMOLYTIC ANAEMIA |
45 |
0.0050 |
| 662 |
HAEMOPTYSIS |
139 |
0.0050 |
| 663 |
DRUG LEVEL INCREASED |
81 |
0.0049 |
| 664 |
ABSCESS |
78 |
0.0049 |
| 665 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
82 |
0.0049 |
| 666 |
RASH ERYTHEMATOUS |
231 |
0.0048 |
| 667 |
OEDEMA |
262 |
0.0048 |
| 668 |
ATRIAL FIBRILLATION |
463 |
0.0047 |
| 669 |
GENERAL PHYSICAL HEALTH DETERIORATION |
541 |
0.0047 |
| 670 |
GASTROINTESTINAL HAEMORRHAGE |
390 |
0.0047 |
| 671 |
CEREBRAL INFARCTION |
114 |
0.0047 |
| 672 |
EYELID PTOSIS |
47 |
0.0046 |
| 673 |
PARALYSIS |
66 |
0.0046 |
| 674 |
RED BLOOD CELL COUNT DECREASED |
131 |
0.0046 |
| 675 |
INTENTIONAL PRODUCT USE ISSUE |
401 |
0.0046 |
| 676 |
HAEMATEMESIS |
116 |
0.0046 |
| 677 |
LIVER FUNCTION TEST ABNORMAL |
133 |
0.0046 |
| 678 |
ALTERED STATE OF CONSCIOUSNESS |
99 |
0.0046 |
| 679 |
ANAL INCONTINENCE |
41 |
0.0046 |
| 680 |
WHITE BLOOD CELL COUNT INCREASED |
174 |
0.0045 |
| 681 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
247 |
0.0045 |
| 682 |
CONVULSION |
256 |
0.0045 |
| 683 |
LIVER DISORDER |
198 |
0.0045 |
| 684 |
HYPOTHERMIA |
45 |
0.0044 |
| 685 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
76 |
0.0044 |
| 686 |
ABDOMINAL PAIN |
1027 |
0.0044 |
| 687 |
MELAENA |
97 |
0.0044 |
| 688 |
CIRCULATORY COLLAPSE |
75 |
0.0044 |
| 689 |
TUBULOINTERSTITIAL NEPHRITIS |
82 |
0.0044 |
| 690 |
PLATELET COUNT INCREASED |
57 |
0.0044 |
| 691 |
BRADYCARDIA |
231 |
0.0044 |
| 692 |
PREMATURE BABY |
131 |
0.0043 |
| 693 |
TREATMENT FAILURE |
357 |
0.0043 |
| 694 |
CARDIOMEGALY |
53 |
0.0043 |
| 695 |
PROCEDURAL COMPLICATION |
33 |
0.0043 |
| 696 |
DRUG INTERACTION |
676 |
0.0043 |
| 697 |
RASH PUSTULAR |
31 |
0.0043 |
| 698 |
HERPES ZOSTER |
241 |
0.0042 |
| 699 |
DEEP VEIN THROMBOSIS |
272 |
0.0042 |
| 700 |
INTERSTITIAL LUNG DISEASE |
202 |
0.0042 |
| 701 |
PYELONEPHRITIS |
36 |
0.0042 |
| 702 |
PALLOR |
113 |
0.0041 |
| 703 |
SEIZURE |
478 |
0.0041 |
| 704 |
HYPERLIPIDAEMIA |
49 |
0.0041 |
| 705 |
BLOOD TRIGLYCERIDES INCREASED |
72 |
0.0041 |
| 706 |
SUDDEN DEATH |
43 |
0.0041 |
| 707 |
DECUBITUS ULCER |
33 |
0.0040 |
| 708 |
OXYGEN SATURATION DECREASED |
227 |
0.0040 |
| 709 |
EPISTAXIS |
302 |
0.0040 |
| 710 |
HYPOTONIA |
40 |
0.0040 |
| 711 |
BRAIN INJURY |
40 |
0.0040 |
| 712 |
BASAL CELL CARCINOMA |
62 |
0.0040 |
| 713 |
PULMONARY EMBOLISM |
375 |
0.0039 |
| 714 |
TOOTH ABSCESS |
40 |
0.0039 |
| 715 |
ASPIRATION |
43 |
0.0039 |
| 716 |
FACE OEDEMA |
66 |
0.0039 |
| 717 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
50 |
0.0039 |
| 718 |
EPILEPSY |
118 |
0.0039 |
| 719 |
ELECTROCARDIOGRAM ABNORMAL |
30 |
0.0038 |
| 720 |
LUNG DISORDER |
187 |
0.0038 |
| 721 |
PERITONITIS |
79 |
0.0038 |
| 722 |
URINARY INCONTINENCE |
113 |
0.0038 |
| 723 |
VOMITING |
1775 |
0.0038 |
| 724 |
GLOMERULAR FILTRATION RATE DECREASED |
46 |
0.0037 |
| 725 |
BLINDNESS |
152 |
0.0037 |
| 726 |
STEVENS-JOHNSON SYNDROME |
82 |
0.0037 |
| 727 |
COVID-19 |
642 |
0.0037 |
| 728 |
ERYTHEMA MULTIFORME |
34 |
0.0036 |
| 729 |
PROTEINURIA |
69 |
0.0036 |
| 730 |
SQUAMOUS CELL CARCINOMA |
34 |
0.0036 |
| 731 |
PULMONARY HYPERTENSION |
75 |
0.0036 |
| 732 |
LACTIC ACIDOSIS |
116 |
0.0036 |
| 733 |
DISORIENTATION |
141 |
0.0036 |
| 734 |
DIPLOPIA |
92 |
0.0035 |
| 735 |
DELIRIUM |
122 |
0.0035 |
| 736 |
MYOCARDIAL ISCHAEMIA |
40 |
0.0035 |
| 737 |
OSTEOMYELITIS |
63 |
0.0035 |
| 738 |
ISCHAEMIC STROKE |
61 |
0.0034 |
| 739 |
INCONTINENCE |
36 |
0.0034 |
| 740 |
METASTASES TO LUNG |
39 |
0.0034 |
| 741 |
CYSTITIS |
107 |
0.0034 |
| 742 |
HEPATIC ENZYME INCREASED |
229 |
0.0034 |
| 743 |
URINARY RETENTION |
111 |
0.0033 |
| 744 |
HAEMORRHAGE |
347 |
0.0033 |
| 745 |
GASTRIC HAEMORRHAGE |
38 |
0.0033 |
| 746 |
PHOTOPHOBIA |
62 |
0.0033 |
| 747 |
GASTROENTERITIS |
48 |
0.0033 |
| 748 |
VASCULITIS |
38 |
0.0033 |
| 749 |
ORAL PAIN |
73 |
0.0033 |
| 750 |
MUSCULAR WEAKNESS |
369 |
0.0032 |
| 751 |
METASTASES TO LIVER |
56 |
0.0032 |
| 752 |
NEURALGIA |
77 |
0.0032 |
| 753 |
BLOOD POTASSIUM DECREASED |
95 |
0.0032 |
| 754 |
GASTROINTESTINAL DISORDER |
280 |
0.0031 |
| 755 |
GINGIVAL BLEEDING |
42 |
0.0031 |
| 756 |
PULMONARY FIBROSIS |
59 |
0.0031 |
| 757 |
UPPER RESPIRATORY TRACT INFECTION |
142 |
0.0031 |
| 758 |
GASTRITIS |
80 |
0.0030 |
| 759 |
PULMONARY CONGESTION |
40 |
0.0030 |
| 760 |
BLOOD SODIUM DECREASED |
57 |
0.0030 |
| 761 |
NODULE |
39 |
0.0030 |
| 762 |
BLOOD PRESSURE DECREASED |
197 |
0.0030 |
| 763 |
COMA |
140 |
0.0029 |
| 764 |
MASS |
41 |
0.0029 |
| 765 |
INTERNATIONAL NORMALISED RATIO INCREASED |
83 |
0.0029 |
| 766 |
PHARYNGITIS |
36 |
0.0029 |
| 767 |
SENSORY DISTURBANCE |
46 |
0.0029 |
| 768 |
HYPERKALAEMIA |
100 |
0.0028 |
| 769 |
PRODUCT USE ISSUE |
532 |
0.0028 |
| 770 |
ORTHOSTATIC HYPOTENSION |
49 |
0.0028 |
| 771 |
IMMUNE SYSTEM DISORDER |
37 |
0.0028 |
| 772 |
TOOTH INFECTION |
37 |
0.0028 |
| 773 |
ANAPHYLACTIC REACTION |
155 |
0.0028 |
| 774 |
DIARRHOEA |
1805 |
0.0028 |
| 775 |
INFUSION RELATED REACTION |
185 |
0.0028 |
| 776 |
HAEMATOMA |
72 |
0.0028 |
| 777 |
CONJUNCTIVITIS |
51 |
0.0027 |
| 778 |
CYANOSIS |
43 |
0.0027 |
| 779 |
ABDOMINAL DISTENSION |
285 |
0.0027 |
| 780 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
194 |
0.0027 |
| 781 |
RESPIRATORY ARREST |
75 |
0.0027 |
| 782 |
HAEMORRHOIDS |
53 |
0.0027 |
| 783 |
FEEDING DISORDER |
55 |
0.0027 |
| 784 |
DYSPNOEA EXERTIONAL |
102 |
0.0027 |
| 785 |
LIVER FUNCTION TEST INCREASED |
58 |
0.0027 |
| 786 |
BONE PAIN |
158 |
0.0027 |
| 787 |
BRONCHOSPASM |
38 |
0.0027 |
| 788 |
HEPATIC CIRRHOSIS |
50 |
0.0027 |
| 789 |
DRUG INTOLERANCE |
255 |
0.0026 |
| 790 |
HYPERTENSION |
557 |
0.0026 |
| 791 |
INTESTINAL OBSTRUCTION |
99 |
0.0026 |
| 792 |
DYSPHAGIA |
249 |
0.0026 |
| 793 |
CHOLELITHIASIS |
86 |
0.0026 |
| 794 |
INFLAMMATION |
135 |
0.0026 |
| 795 |
ILL-DEFINED DISORDER |
157 |
0.0026 |
| 796 |
MYDRIASIS |
33 |
0.0026 |
| 797 |
DEAFNESS |
67 |
0.0026 |
| 798 |
DECREASED APPETITE |
594 |
0.0026 |
| 799 |
ACUTE MYOCARDIAL INFARCTION |
74 |
0.0025 |
| 800 |
SARS-COV-2 TEST POSITIVE |
33 |
0.0025 |
| 801 |
PULMONARY ARTERIAL HYPERTENSION |
36 |
0.0025 |
| 802 |
PRODUCT PRESCRIBING ISSUE |
54 |
0.0025 |
| 803 |
CONFUSIONAL STATE |
400 |
0.0025 |
| 804 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
63 |
0.0024 |
| 805 |
THERAPEUTIC RESPONSE DECREASED |
148 |
0.0024 |
| 806 |
DRUG INEFFECTIVE |
3207 |
0.0024 |
| 807 |
ARRHYTHMIA |
114 |
0.0024 |
| 808 |
DEATH |
2066 |
0.0024 |
| 809 |
NAUSEA |
1896 |
0.0024 |
| 810 |
DEHYDRATION |
317 |
0.0024 |
| 811 |
PNEUMONIA ASPIRATION |
59 |
0.0024 |
| 812 |
COGNITIVE DISORDER |
110 |
0.0024 |
| 813 |
PRESYNCOPE |
57 |
0.0023 |
| 814 |
OEDEMA PERIPHERAL |
277 |
0.0023 |
| 815 |
MUSCULOSKELETAL CHEST PAIN |
35 |
0.0023 |
| 816 |
RENAL INJURY |
67 |
0.0023 |
| 817 |
PRODUCTIVE COUGH |
107 |
0.0022 |
| 818 |
RASH PAPULAR |
50 |
0.0022 |
| 819 |
LETHARGY |
128 |
0.0022 |
| 820 |
ASTHENIA |
825 |
0.0022 |
| 821 |
POST PROCEDURAL COMPLICATION |
42 |
0.0022 |
| 822 |
BLOOD COUNT ABNORMAL |
33 |
0.0022 |
| 823 |
DRUG EFFECT INCOMPLETE |
79 |
0.0022 |
| 824 |
DYSURIA |
80 |
0.0022 |
| 825 |
HYPOGLYCAEMIA |
105 |
0.0022 |
| 826 |
COUGH |
605 |
0.0022 |
| 827 |
RECTAL HAEMORRHAGE |
92 |
0.0021 |
| 828 |
HALLUCINATION, VISUAL |
45 |
0.0021 |
| 829 |
DERMATITIS |
44 |
0.0021 |
| 830 |
BLOOD POTASSIUM INCREASED |
34 |
0.0021 |
| 831 |
SYNCOPE |
206 |
0.0021 |
| 832 |
ANAPHYLACTIC SHOCK |
53 |
0.0021 |
| 833 |
CONDITION AGGRAVATED |
613 |
0.0020 |
| 834 |
ULCER |
32 |
0.0020 |
| 835 |
DIVERTICULITIS |
55 |
0.0020 |
| 836 |
CARDIAC FAILURE CONGESTIVE |
159 |
0.0020 |
| 837 |
SKIN DISORDER |
66 |
0.0020 |
| 838 |
HEART RATE INCREASED |
196 |
0.0020 |
| 839 |
ABDOMINAL PAIN LOWER |
50 |
0.0020 |
| 840 |
RENAL DISORDER |
92 |
0.0020 |
| 841 |
AGITATION |
145 |
0.0020 |
| 842 |
RASH PRURITIC |
107 |
0.0020 |
| 843 |
THROMBOSIS |
158 |
0.0020 |
| 844 |
RASH |
854 |
0.0020 |
| 845 |
FAECES DISCOLOURED |
42 |
0.0019 |
| 846 |
RHINORRHOEA |
124 |
0.0019 |
| 847 |
HAEMATOCHEZIA |
104 |
0.0019 |
| 848 |
SEROTONIN SYNDROME |
36 |
0.0019 |
| 849 |
OROPHARYNGEAL PAIN |
172 |
0.0019 |
| 850 |
SINUSITIS |
190 |
0.0019 |
| 851 |
CONSTIPATION |
391 |
0.0018 |
| 852 |
VISUAL ACUITY REDUCED |
59 |
0.0018 |
| 853 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
51 |
0.0018 |
| 854 |
OSTEONECROSIS OF JAW |
43 |
0.0017 |
| 855 |
HEADACHE |
1083 |
0.0017 |
| 856 |
PLASMA CELL MYELOMA |
67 |
0.0017 |
| 857 |
DYSPNOEA |
964 |
0.0017 |
| 858 |
RETCHING |
36 |
0.0017 |
| 859 |
URINARY TRACT INFECTION |
282 |
0.0017 |
| 860 |
MATERNAL EXPOSURE DURING PREGNANCY |
147 |
0.0016 |
| 861 |
EATING DISORDER |
35 |
0.0016 |
| 862 |
BACK PAIN |
378 |
0.0016 |
| 863 |
LABORATORY TEST ABNORMAL |
48 |
0.0016 |
| 864 |
ERYTHEMA |
328 |
0.0016 |
| 865 |
PSYCHOTIC DISORDER |
47 |
0.0016 |
| 866 |
NIGHT SWEATS |
51 |
0.0016 |
| 867 |
RHABDOMYOLYSIS |
66 |
0.0016 |
| 868 |
MUSCULOSKELETAL DISORDER |
30 |
0.0016 |
| 869 |
HYPOAESTHESIA |
233 |
0.0016 |
| 870 |
PARAESTHESIA |
243 |
0.0015 |
| 871 |
CHEST PAIN |
285 |
0.0015 |
| 872 |
FLUID RETENTION |
78 |
0.0015 |
| 873 |
FOETAL EXPOSURE DURING PREGNANCY |
122 |
0.0015 |
| 874 |
ANGIOEDEMA |
65 |
0.0015 |
| 875 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
43 |
0.0015 |
| 876 |
LOSS OF CONSCIOUSNESS |
188 |
0.0015 |
| 877 |
CARDIOVASCULAR DISORDER |
37 |
0.0015 |
| 878 |
PAIN IN JAW |
41 |
0.0014 |
| 879 |
HYPOTHYROIDISM |
46 |
0.0014 |
| 880 |
EXPOSURE DURING PREGNANCY |
85 |
0.0014 |
| 881 |
MENTAL IMPAIRMENT |
33 |
0.0014 |
| 882 |
VAGINAL HAEMORRHAGE |
59 |
0.0014 |
| 883 |
SKIN ULCER |
35 |
0.0014 |
| 884 |
CHEST DISCOMFORT |
137 |
0.0013 |
| 885 |
DYSKINESIA |
54 |
0.0013 |
| 886 |
INFLUENZA |
148 |
0.0013 |
| 887 |
SPEECH DISORDER |
69 |
0.0013 |
| 888 |
OESOPHAGEAL CARCINOMA |
39 |
0.0013 |
| 889 |
TYPE 2 DIABETES MELLITUS |
43 |
0.0013 |
| 890 |
SKIN EXFOLIATION |
107 |
0.0013 |
| 891 |
CEREBROVASCULAR ACCIDENT |
214 |
0.0013 |
| 892 |
GAIT DISTURBANCE |
237 |
0.0012 |
| 893 |
RASH GENERALISED |
32 |
0.0012 |
| 894 |
TRANSIENT ISCHAEMIC ATTACK |
41 |
0.0012 |
| 895 |
PAIN IN EXTREMITY |
356 |
0.0012 |
| 896 |
DRUG EXPOSURE DURING PREGNANCY |
41 |
0.0012 |
| 897 |
HYPERSENSITIVITY |
220 |
0.0012 |
| 898 |
GASTRIC CANCER |
30 |
0.0012 |
| 899 |
NEOPLASM MALIGNANT |
78 |
0.0012 |
| 900 |
NECK PAIN |
65 |
0.0012 |
| 901 |
RASH MACULAR |
40 |
0.0011 |
| 902 |
HEAD INJURY |
36 |
0.0011 |
| 903 |
DYSSTASIA |
33 |
0.0011 |
| 904 |
MYALGIA |
191 |
0.0011 |
| 905 |
GAIT INABILITY |
37 |
0.0011 |
| 906 |
IMPAIRED HEALING |
36 |
0.0011 |
| 907 |
CARDIAC DISORDER |
102 |
0.0011 |
| 908 |
WEIGHT DECREASED |
303 |
0.0011 |
| 909 |
HEART RATE DECREASED |
38 |
0.0011 |
| 910 |
SOMNOLENCE |
217 |
0.0011 |
| 911 |
PRURITUS |
410 |
0.0011 |
| 912 |
TREMOR |
175 |
0.0011 |
| 913 |
DISCOMFORT |
63 |
0.0010 |
| 914 |
EYE PAIN |
58 |
0.0010 |
| 915 |
CORONARY ARTERY DISEASE |
31 |
0.0010 |
| 916 |
FATIGUE |
787 |
0.0010 |
| 917 |
HYPERHIDROSIS |
130 |
0.0010 |
| 918 |
HALLUCINATION |
76 |
0.0010 |
| 919 |
NEPHROLITHIASIS |
46 |
0.0010 |
| 920 |
BLISTER |
56 |
0.0010 |
| 921 |
DIABETES MELLITUS |
76 |
0.0010 |
| 922 |
FLUSHING |
100 |
0.0010 |
| 923 |
BALANCE DISORDER |
85 |
0.0010 |
| 924 |
WEIGHT INCREASED |
217 |
0.0010 |
| 925 |
SWELLING FACE |
63 |
0.0010 |
| 926 |
VISION BLURRED |
132 |
0.0010 |
| 927 |
MEDICATION ERROR |
52 |
0.0009 |
| 928 |
EYE DISORDER |
30 |
0.0009 |
| 929 |
DYSGEUSIA |
67 |
0.0009 |
| 930 |
RESTLESSNESS |
33 |
0.0009 |
| 931 |
DRY EYE |
45 |
0.0009 |
| 932 |
IRRITABILITY |
54 |
0.0009 |
| 933 |
ADVERSE EVENT |
82 |
0.0009 |
| 934 |
BLOOD CHOLESTEROL INCREASED |
41 |
0.0009 |
| 935 |
OSTEOPOROSIS |
36 |
0.0009 |
| 936 |
PALPITATIONS |
102 |
0.0009 |
| 937 |
TINNITUS |
40 |
0.0009 |
| 938 |
BRONCHITIS |
64 |
0.0009 |
| 939 |
MUSCULOSKELETAL PAIN |
44 |
0.0008 |
| 940 |
DISTURBANCE IN ATTENTION |
45 |
0.0008 |
| 941 |
ABDOMINAL PAIN UPPER |
171 |
0.0008 |
| 942 |
SKIN DISCOLOURATION |
38 |
0.0008 |
| 943 |
MOBILITY DECREASED |
59 |
0.0008 |
| 944 |
GASTROOESOPHAGEAL REFLUX DISEASE |
64 |
0.0008 |
| 945 |
NO ADVERSE EVENT |
144 |
0.0008 |
| 946 |
SWELLING |
73 |
0.0008 |
| 947 |
CONTUSION |
74 |
0.0008 |
| 948 |
POLLAKIURIA |
32 |
0.0008 |
| 949 |
PAIN |
469 |
0.0008 |
| 950 |
MENTAL DISORDER |
33 |
0.0008 |
| 951 |
ABNORMAL BEHAVIOUR |
30 |
0.0008 |
| 952 |
TREATMENT NONCOMPLIANCE |
41 |
0.0007 |
| 953 |
NASAL CONGESTION |
44 |
0.0007 |
| 954 |
DIZZINESS |
367 |
0.0007 |
| 955 |
MYOCARDIAL INFARCTION |
123 |
0.0007 |
| 956 |
FALL |
231 |
0.0007 |
| 957 |
CHRONIC KIDNEY DISEASE |
52 |
0.0007 |
| 958 |
WHEEZING |
40 |
0.0007 |
| 959 |
MALAISE |
295 |
0.0007 |
| 960 |
VISUAL IMPAIRMENT |
83 |
0.0007 |
| 961 |
DRUG EFFECT DECREASED |
35 |
0.0006 |
| 962 |
THERAPY INTERRUPTED |
46 |
0.0006 |
| 963 |
BLOOD PRESSURE INCREASED |
95 |
0.0006 |
| 964 |
AGGRESSION |
31 |
0.0006 |
| 965 |
BLOOD GLUCOSE INCREASED |
115 |
0.0006 |
| 966 |
ALOPECIA |
119 |
0.0006 |
| 967 |
ARTHRALGIA |
246 |
0.0006 |
| 968 |
URTICARIA |
98 |
0.0006 |
| 969 |
FLATULENCE |
32 |
0.0006 |
| 970 |
DYSPEPSIA |
55 |
0.0006 |
| 971 |
UNEVALUABLE EVENT |
42 |
0.0006 |
| 972 |
AMNESIA |
33 |
0.0005 |
| 973 |
ABDOMINAL DISCOMFORT |
83 |
0.0005 |
| 974 |
ANXIETY |
138 |
0.0005 |
| 975 |
MEMORY IMPAIRMENT |
64 |
0.0005 |
| 976 |
MUSCULOSKELETAL STIFFNESS |
40 |
0.0005 |
| 977 |
DRY MOUTH |
35 |
0.0004 |
| 978 |
DEPRESSION |
97 |
0.0004 |
| 979 |
PROSTATE CANCER |
31 |
0.0004 |
| 980 |
PERIPHERAL SWELLING |
50 |
0.0003 |
| 981 |
HOSPITALISATION |
47 |
0.0003 |
| 982 |
MUSCLE SPASMS |
55 |
0.0003 |
| 983 |
INSOMNIA |
71 |
0.0003 |
| 984 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
46 |
0.0003 |
| 985 |
OVERDOSE |
55 |
0.0003 |
| 986 |
DRY SKIN |
33 |
0.0002 |
| 987 |
NASOPHARYNGITIS |
42 |
0.0002 |
| 988 |
FEELING ABNORMAL |
38 |
0.0002 |